Unknown

Dataset Information

0

Distal mutation V486M disrupts the catalytic activity of DPP4 by affecting the flap of the propeller domain.


ABSTRACT: Dipeptidyl peptidase-4 (DPP4) plays a crucial role in regulating the bioactivity of glucagon-like peptide-1 (GLP-1) that enhances insulin secretion and pancreatic β-cell proliferation, making it a therapeutic target for type 2 diabetes. Although the crystal structure of DPP4 has been determined, its structure-function mechanism is largely unknown. Here, we examined the biochemical properties of sporadic human DPP4 mutations distal from its catalytic site, among which V486M ablates DPP4 dimerization and causes loss of enzymatic activity. Unbiased molecular dynamics simulations revealed that the distal V486M mutation induces a local conformational collapse in a β-propeller loop (residues 234-260, defined as the flap) and disrupts the dimerization of DPP4. The "open/closed" conformational transitions of the flap whereby capping the active site, are involved in the enzymatic activity of DPP4. Further site-directed mutagenesis guided by theoretical predictions verified the importance of the conformational dynamics of the flap for the enzymatic activity of DPP4. Therefore, the current studies that combined theoretical modeling and experimental identification, provide important insights into the biological function of DPP4 and allow for the evaluation of directed DPP4 genetic mutations before initiating clinical applications and drug development.

SUBMITTER: Li TT 

PROVIDER: S-EPMC8669218 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Distal mutation V486M disrupts the catalytic activity of DPP4 by affecting the flap of the propeller domain.

Li Teng-Teng TT   Peng Cheng C   Wang Ji-Qiu JQ   Xu Zhi-Jian ZJ   Su Ming-Bo MB   Li Jia J   Zhu Wei-Liang WL   Li Jing-Ya JY  

Acta pharmacologica Sinica 20211214 8


Dipeptidyl peptidase-4 (DPP4) plays a crucial role in regulating the bioactivity of glucagon-like peptide-1 (GLP-1) that enhances insulin secretion and pancreatic β-cell proliferation, making it a therapeutic target for type 2 diabetes. Although the crystal structure of DPP4 has been determined, its structure-function mechanism is largely unknown. Here, we examined the biochemical properties of sporadic human DPP4 mutations distal from its catalytic site, among which V486M ablates DPP4 dimerizat  ...[more]

Similar Datasets

| S-EPMC7152759 | biostudies-literature
| S-EPMC6360277 | biostudies-literature
| S-EPMC11601903 | biostudies-literature
| S-EPMC2144480 | biostudies-literature
| S-EPMC5053009 | biostudies-literature
| S-EPMC3572540 | biostudies-literature
| S-EPMC7692748 | biostudies-literature
| S-EPMC151815 | biostudies-literature
| S-EPMC10462681 | biostudies-literature
| S-EPMC7513720 | biostudies-literature